Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TGTXthis companyTG Therapeutics, Inc.	$55.77	9.62×	6.64×	6.98×	33.37×	-192.3%	83.7%	20.0%	72.6%	69.0%	13.5%	-0.6%	0.4×	1.35×	4.61×	4.1×	0.0%	5	5.82	3	B
CLDXCelldex Therapeutics, Inc.	$31.21	-6.96×	3.43×	1,204.09×	-6.97×	-99.2%	100.0%	-19160.0%	-17253.3%	-49.1%	-53.9%	-11.8%	0×	0.1×	0×	10.49×	0.0%	2	16.42	2	C
CRVSCorvus Pharmaceuticals, Inc.	$11.10	-40.53×	9.93×	0×	-39.82×	-99.8%	0.0%	0.0%	0.0%	-25.0%	-69.1%	-5.4%	0.02×	0.24×	0×	6.21×	0.0%	2	32.84	2	C
MGNXMacroGenics, Inc.	$2.44	-1.36×	1.83×	0.68×	-2.54×	-2714.5%	71.1%	-48.7%	-49.9%	-134.2%	-33.0%	-81.6%	1.92×	-0.83×	-8.56×	5.1×	0.0%	1	-4.43	1	D+
XNCRXencor, Inc.	$38.36	-12.35×	1.79×	9.05×	-27.04×	-122.2%	91.6%	-141.4%	-73.2%	-14.5%	-21.5%	-12.2%	0.3×	-2.85×	-5.56×	6.25×	0.0%	2	4.41	2	C
Peer median	—	-9.66×	2.63×	4.87×	-17×	-111.0%	81.4%	-95.0%	-61.6%	-37.0%	-43.4%	-12.0%	0.16×	-0.36×	-2.78×	6.23×	0.0%	2	10.41	2	—